GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sartorius AG (OTCPK:SARTF) » Definitions » 5-Year Yield-on-Cost %
中文

Sartorius AG (Sartorius AG) 5-Year Yield-on-Cost % : 1.08 (As of Apr. 25, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Sartorius AG 5-Year Yield-on-Cost %?

Sartorius AG's yield on cost for the quarter that ended in Mar. 2024 was 1.08.


The historical rank and industry rank for Sartorius AG's 5-Year Yield-on-Cost % or its related term are showing as below:

SARTF' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.25   Med: 1.49   Max: 3.84
Current: 1.08


During the past 13 years, Sartorius AG's highest Yield on Cost was 3.84. The lowest was 0.25. And the median was 1.49.


SARTF's 5-Year Yield-on-Cost % is ranked worse than
81.99% of 311 companies
in the Medical Devices & Instruments industry
Industry Median: 2.26 vs SARTF: 1.08

Competitive Comparison of Sartorius AG's 5-Year Yield-on-Cost %

For the Medical Instruments & Supplies subindustry, Sartorius AG's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sartorius AG's 5-Year Yield-on-Cost % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sartorius AG's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Sartorius AG's 5-Year Yield-on-Cost % falls into.



Sartorius AG 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Sartorius AG is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Sartorius AG  (OTCPK:SARTF) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Sartorius AG 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Sartorius AG's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Sartorius AG (Sartorius AG) Business Description

Address
Otto-Brenner-Strasse 20, Gottingen, NI, DEU, 37079
Sartorius AG is a leading provider of bioprocessing solutions. Its Bioprocess division sells equipment and consumables for upstream and downstream manufacturing of biologic drugs, and has a focus on single-use technology, or SUT. Its Lab Products and Services division offers a wide range of products for lab use, including scales, pipettes, and filtration equipment. As of 2022, the Bioprocess and LPS divisions contributed 80% and 20% of revenue, respectively. Bioprocess is housed in its subsidiary Sartorius Stedim Biotech, of which Sartorius AG has a 74% ownership and 85% voting control. The business is geographically diverse, with revenue across Europe, the Middle East, and Africa (37% of 2022 sales), the Americas (37%), and Asia-Pacific (26%). We estimate China revenue to be around 10%.

Sartorius AG (Sartorius AG) Headlines

From GuruFocus

Sartorius with first-quarter uptick in sales and earnings

By PRNewswire PRNewswire 04-21-2021

Strong profitable growth at Sartorius

By PRNewswire PRNewswire 10-20-2020

Sartorius acquires cell culture specialist Xell AG

By PRNewswire PRNewswire 07-29-2021

Sartorius with clear double-digit growth in fiscal 2022

By PRNewswire PRNewswire 01-26-2023

Sartorius to expand Business Operations in North America

By PRNewswire PRNewswire 09-27-2021

Sartorius closes acquisition of BIA Separations

By PRNewswire PRNewswire 11-02-2020

Sartorius significantly expands activities in South Korea

By PRNewswire PRNewswire 11-25-2021

Sartorius presents annual report for 2021

By PRNewswire PRNewswire 02-17-2022